News
The new liver-directed, selective THR-Ī² agonists, such as resmetirom, help regulate intrahepatic thyroid hormone concentrations in patients with MASLD/MASH, potentially addressing the underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback